|
Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer
|
3UM1CA186704-04S1
|
$170,500
|
ABBRUZZESE, JAMES
|
DUKE UNIVERSITY
|
|
Leveraging polyamine metabolic stress as a novel therapy for prostate cancer
|
4K00CA212455-03
|
$69,749
|
AFFRONTI, HAYLEY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Modeling and druggable-genome screening of glioblastoma invasion using regional biopsy-guided biomaterials systems
|
1R01CA227136-01A1
|
$454,956
|
AGHI, MANISH
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation
|
4R44CA203336-02
|
$659,516
|
AGUILAR-CORDOVA, ESTUARDO
|
ADVANTAGENE, INC
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach (1 of 2
|
3U54CA137788-10S1
|
$54,859
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach (1 of 2
|
3U54CA137788-10S2
|
$188,884
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
|
7R01CA182076-05
|
$339,622
|
ALLEN, PETER
|
DUKE UNIVERSITY
|
|
Novel Strategies for Precision T-cell Therapies
|
3R01CA198095-03S1
|
$107,431
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S2
|
$200,000
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer
|
4R00CA204593-03
|
$249,000
|
ALTMAN, BRIAN
|
UNIVERSITY OF ROCHESTER
|
|
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence
|
3R01CA208042-03S1
|
$223,893
|
ALVAREZ, JAMES
|
DUKE UNIVERSITY
|
|
Research Supplements to Promote Sharing Data in Cancer Epidemiology Studies
|
3U19CA203654-02S1
|
$147,830
|
AMOS, CHRISTOPHER
|
BAYLOR COLLEGE OF MEDICINE
|
|
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells
|
3R01AR070234-04S1
|
$55,691
|
ANANDASABAPATHY, NIROSHANA
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Disruption of T cell tolerance in type 1 diabetes
|
3P01AI118688-03S1
|
$52,804
|
ANDERSON, MARK
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Womens Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S3
|
$175,562
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Childhood Cancer Survivor Study
|
3U24CA055727-24S1
|
$120,439
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Stanford Cancer Institute
|
3P30CA124435-11S1
|
$248,520
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-09S1
|
$249,371
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$425,206
|
Arthur, Diane
|
CCR (NCI)
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$312,671
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Regulation and Consequences of Ubiquitination
|
ZIA BC 010779
|
$312,671
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Glucocorticoids and T cell development and function
|
ZIA BC 011264
|
$312,671
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Dissecting the role of serine metabolism in tumor initiating stem cells
|
1F31CA236465-01
|
$49,524
|
BAKSH, SANJEETHAN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
2/2 The GUIDE Cancer Research Training Project
|
3P20CA202907-04S1
|
$48,872
|
BALTHAZAR, CATHERINE
|
GOVERNORS STATE UNIVERSITY
|
|
Dual View Endoscopy for Colonoscopy
|
2R42CA203212-02
|
$872,389
|
BANERJEE, BHASKAR
|
OMNISCIENT, LLC
|
|
Modeling the genetic complexity of colorectal cancer in Drosophila
|
7R03CA219321-02
|
$76,541
|
BANGI, ERDEM
|
FLORIDA STATE UNIVERSITY
|
|
FOXM1-RHNO1 Oncogenic Axis in Ovarian Cancer
|
4K00CA212470-03
|
$71,280
|
BARGER, CARTER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Inflammation and gynecologic cancer: the role of prostaglandins in ovarian cancer
|
4K00CA212222-03
|
$88,280
|
BARNARD, MOLLIE
|
UNIVERSITY OF UTAH
|
|
Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries
|
4UH3CA202721-03
|
$513,260
|
BASU, PARTHA
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
Inflammation and Cardiovascular Disease in Rheumatoid Arthritis
|
3R01AR050026-13S1
|
$53,333
|
BATHON, JOAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA042014-29S5
|
$59,693
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S6
|
$155,422
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
The role of AXL-ABL axis in Barretts carcinogenesis
|
3R01CA193219-04S1
|
$58,182
|
BELKHIRI, ABBES
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA022453-36S2
|
$351,933
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA022453-36S3
|
$89,993
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA022453-36S4
|
$127,646
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Administrative Supplement to Cancer Center Support Grant to Support Acquisition and Annotation of Biospecimens
|
3P30CA022453-36S5
|
$46,200
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Impact of Cytoskeletal Regulators on Cancer Cell Stromal Invasion
|
4K00CA212132-03
|
$71,280
|
BERENS, ERIC
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
AN IMAGING-BASED APPROACH TO UNDERSTAND AND PREDICT CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY
|
3R01CA208623-02S3
|
$168,645
|
BEREZIN, MIKHAIL
|
WASHINGTON UNIVERSITY
|
|
Epigenetic regulation by tumor suppressor p53
|
3R01CA078831-19S1
|
$54,452
|
BERGER, SHELLEY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Risk in Pediatric-Onset Rheumatic Disease
|
1R03CA149970-01A1
|
$47,322
|
Bernatsky, Sasha
|
MCGILL UNIVERSITY HEALTH CTR RES INST
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-05S2
|
$1,000,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|